Anzeige
Mehr »
Login
Freitag, 31.01.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Gold-Rally Richtung 3.000 $: Der brasilianische Gold-Play, das Sie kennen sollten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40RA7 | ISIN: CA2059531020 | Ticker-Symbol: YU1
Frankfurt
30.01.25
08:03 Uhr
0,470 Euro
-0,012
-2,49 %
1-Jahres-Chart
CONAVI MEDICAL CORP Chart 1 Jahr
5-Tage-Chart
CONAVI MEDICAL CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,4120,56030.01.

Aktuelle News zur CONAVI MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CONAVI MEDICAL Aktie jetzt für 0€ handeln
DoConavi Medical Corp. Announces Proposed Public Offering of Units1
23.01.Conavi Medical Corp.: Conavi Medical Provides Shareholder Update and 2025 Outlook92- U.S. FDA 510(k) filing of next-generation Novasight system targeted for H2 2025 with U.S. commercial launch planned for early 2026- Evolving medical guidelines position next-generation Novasight...
► Artikel lesen
07.01.Conavi Medical Corp.: Conavi Medical and Minnetronix Medical Publish In-Depth Collaboration Review103TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTC: CNVIF) ("Conavi Medical" or the "Company"), a commercial stage medical device company focused on designing, manufacturing...
► Artikel lesen
06.01.Conavi Medical Corp: Conavi Medical grants options to buy 1.07M shares1
06.01.Conavi Medical Corp.: Conavi Medical Announces Grant of Stock Options2
19.12.24Conavi Medical Corp: Conavi loses $43.6-million (U.S.) in fiscal 20242
19.12.24Conavi Medical Corp. GAAP EPS of -$7.08-
19.12.24Conavi Medical Corp.: Conavi Medical Reports Fiscal 2024 Financial Results and Operational Highlights117- Completed US$7.7 million financing and reverse takeover to take Company public - Chinese partner achieved regulatory approval, setting stage for royalty stream and triggering US$5.9 million payment...
► Artikel lesen
09.12.24Conavi Medical Corp: Conavi's China partner coronary imaging system gets OK1
09.12.24Conavi Medical Inc.: China's NMPA Approves EOM's Coronary Imaging System Based on Conavi Medical's IP1
05.12.24Toronto Stock Exchange: Conavi Medical Inc. (CNVI) Opens the Market268Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Thomas Looby, Chief Executive Officer, Conavi Medical Inc. (TSXV: CNVI) ("Conavi Medical" or the "Company"), and his team, joined Dani Lipkin...
► Artikel lesen
28.10.24Conavi Medical Corp: Conavi talks peer-reviewed cardiovascular article2
28.10.24Conavi Medical Inc.: JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies2
22.10.24Conavi Medical Corp: Conavi hires ICP for automated market-making services2
22.10.24Conavi Medical Inc.: Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services4
16.10.24Conavi Medical Corp: Conavi Medical begins trading on TSX-V3
16.10.24Conavi Medical Corp. Commences Trading on TSX-V Under Symbol "CNVI"169TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, "Titan Medical Inc.") ("Conavi" or the "Company") (TSXV: CNVI) is pleased to announce that, pursuant to its press releases...
► Artikel lesen
16.10.24XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 16.10.2024303The following instruments on XETRA do have their first trading 16.10.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 16.10.2024 Aktien 1 MX01TR0H0006 Grupo Traxion S.A.B....
► Artikel lesen
15.10.24XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.10.2024297The following instruments on Boerse Frankfurt do have their last trading day on 15.10.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.10.2024ISIN NameCA88830X8199 TITAN...
► Artikel lesen
15.10.24XFRA ISIN CHANGE353Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenVGG012121023 Agba Group Holding Ltd. 15.10.2024 US8959701017 Triller Group Inc. 16.10.2024 Tausch 4:1CA88830X8199 Titan...
► Artikel lesen
Seite:  Weiter >>
59 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1